Chicago, Oct. 02, 2025 (GLOBE NEWSWIRE) -- The global stem cell manufacturing market was valued at US$ 24.26 billion in 2024 and is projected to reach US$ 65.49 billion by 2033, growing at a CAGR of ...
"This means that we more like closed the gap for the first stage," Xie says. To support large-scale manufacturing, the scientists use suspension bioreactors, or vessels that sustain a biologically ...
Knowing which stem cell characteristics to optimize during the manufacturing process is among the biggest challenges still facing the cell therapy industry. That’s according to Greg Fiore, MD, CEO of ...
Human pluripotent stem cells (hPSCs) have long been viewed as one of regenerative medicine’s most promising raw materials. Now, as more than 100 clinical trials evaluate hPSC-derived therapies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results